Compare Qurate Retail Inc Series A (QVCAQ) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Qurate Retail Inc Series A vs State Street SPDR S&P Biotech ETF — how do they compare? Qurate Retail Inc Series A trades at $0.04 (market cap $653.75K), while State Street SPDR S&P Biotech ETF trades at $151.96. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Qurate Retail Inc Series A nearer its low. Which is the better fit depends on your goals.
| QVCAQ | XBI | |
|---|---|---|
Market Cap | $653.75K | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $15.03 | $164.28 |
52-Week Low | $0.05 | $85.16 |
Enterprise Value | $4.73B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
